Comparable efficacy and safety of treatment with biological agents etanercept and anakinra in children with Juvenile Idiopathic Arthritis in Latvia
β Scribed by D. Guseinova; V. Stanevicha; R. Shantere; D. Berzina; A. Schegolevs; D. Balode; A. Uruma
- Book ID
- 113684490
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 52 KB
- Volume
- 75
- Category
- Article
- ISSN
- 1297-319X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticularβcourse juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye
## Abstract ## Objective To evaluate the effects of longβterm etanercept treatment, with or without methotrexate, on growth in children with selected categories of juvenile idiopathic arthritis (JIA). ## Methods We conducted a 3βyear, openβlabel, nonrandomized registry of 594 patients with polya